Foot and Ankle Masterclass Launches in Manly

[vc_row][vc_column][vc_column_text]The Masterclass is an interactive, hands-on experience for selected members of the sales team, with all three courses progressing to higher difficulty over an eighteen month period.

Course 1 focused on anatomy, pathology, treatment options and sawbone workshops. Distal Extremities Product Managers James Foster and Clark Vickery were on hand to teach this masterclass.

It proved to be extremely beneficial for our Orthopaedic Sales Representatives, who got the chance to build their skill sets and work with many of the Arthrex products.

These masterclass events have become incredibly important in ensuring that Device Technologies continues to uphold a high standard within the Australian and New Zealand healthcare landscape.

“It’s important to do workshops like this, because we want our sales force to be trained up to the highest quality possible,” says Clark.

“[Having these events ensure] that we can service our customers and our surgeons to their expectations, and to be the ultimate resource in the industry for surgeons, so that they think of Device Technologies and Arthrex as the people to go to, and trust.”

The Masterclass was spread over two days, but for the Orthopaedic Sales Representatives, the educational aspect will continue far beyond the end of the courses.

“Following these workshops, what will happen is each member will be responsible for running a masterclass follow up session on a monthly basis,” elaborates James.

“They will also be responsible for adding that additional educational component to the rest of the sales force who aren’t in the Masterclass. They’ll also be helping structure sales, sales strategy and also helping the rest of the team on that complete pathology-based packet sell, rather than just a product sell.”

Events like this have highlighted Arthrex’s expanding portfolio, and also its growing reputation as a go to name for Orthopaedic products within the Australian-New Zealand market.

“Arthrex are known for soft-tissue, but they’ve added to their portfolio lots of plates and screws to encompass the entire pathology,” explains Clark.

“So, surgeons can be confident that they have everything they need to treat the entire pathology at hand. So that includes plates, screws, and soft tissue products.”[/vc_column_text][/vc_column][/vc_row]

Turning MedTech Ideas Into Action

[vc_row][vc_column][vc_column_text]The Actuator is Australia’s premier medical technology commercialisation initiative: priming, augmenting and developing our state-based innovation ecosystems through a nationally-focused strategy. The Actuator employs a unique, powerful and differentiated approach that:

  1. is industry-led;
  2. activates players across the entire innovation spectrum;
  3. augments local ecosystems; and
  4. fosters an unwavering technology commercialisation focus.

Wherever an idea or venture is on the commercialisation pathway, the Actuator has a program designed to smooth its journey and accelerate its development, with a mission to catapult Australia into its rightful place at the head of the global innovation race. They are also home to Australia’s largest and longest-standing early-stage MedTech startup entrepreneurship program – MedTech’s Got Talent

The Actuator has announced the opening of round 2 of its Actuator Accelerator – the nation’s first industry-led, VC-backed 15-month Medtech acceleration program which simultaneously accelerates technology development, builds team capability and provides a pathway to $2.7 million in equity funding. Applications close on 27th April for a July 2018 intake.

For more details and or to apply, visit: http://medtechactuator.com/programs

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”1734″ img_size=”full”][/vc_column][/vc_row]

NSW Minister for Women Pays Tribute to Women in MedTech

This year the theme – press for progress – is a live issue globally and something the MedTech industry is actively pursuing.

The MTAA and the MedTech industry are leading the debate to promote the benefits of gender diversity in the workplace. Just last month the Workplace Gender Equality Agency recognised Baxter Healthcare, Becton Dickinson and Johnson & Johnson as leaders in workplace gender equality.

Speaking at the event, Minister Davies said the NSW Government was building a health system the people of NSW need and, as a result, creating exciting work opportunities for women in STEM.

“As a government, we are absolutely committed to encouraging more women to join the medical technology sector, and leadership from MTAA is vital to achieving real change,” Ms Davies said.

MTAA CEO, Ian Burgess, said the industry was pleased to see the healthcare sector has the highest proportion of women in senior leadership roles across any industry with 70.3 per cent, but also indicated there was more work to be done.

“Which is why later this year MTAA will be releasing a White Paper on practices to further promote gender diversity in the MedTech industry.

“We thank the Minister for coming to speak to us and we look forward to seeing the recipients of the 2018 Premier’s Award for Women of the Year,” Mr Burgess said.